Cargando…

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes

AIM: The aim of this study was to investigate how patients’ expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction. METHODS: The Expectations about Insulin Therapy (EAITQ) and the Experience with Insulin Therapy Questionnaires (EWITQ) were administered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naegeli, A N, Hayes, R P
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904491/ https://www.ncbi.nlm.nih.gov/pubmed/20370840 http://dx.doi.org/10.1111/j.1742-1241.2010.02363.x

Ejemplares similares

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries
por: Boels, Anne Meike, et al.
Publicado: (2017)

Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
por: Landgraf, Wolfgang, et al.
Publicado: (2016)

The Insulin Treatment Satisfaction Questionnaire and Assessment of Satisfaction with a Latest-generation Insulin Pump
por: Bromba, Michael, et al.
Publicado: (2015)

A Non-obese, Treatment-Naive Japanese Diabetic Patient With Elevated Insulin Clearance and Hyperglycemia Under Enhanced Insulin Sensitivity and Increased Insulin Secretion: Elevated Insulin Clearance as Type 2 Japanese Diabetes Mellitus (T2JDM)
por: Sugiyama, Seigo, et al.
Publicado: (2021)

Insulin Therapy for Type 2 Diabetes
por: Swinnen, Sanne G., et al.
Publicado: (2009)

Alpha and Beta Cell Dysfunction Improves With Effective Insulin Therapy in Treatment Naive Type 2 Diabetes - a Prospective Observational Study
por: Ramesh, Jayanthy, et al.
Publicado: (2021)

Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes
por: Nallicheri, Armaan, et al.
Publicado: (2022)

Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience
por: Oner, Hatice, et al.
Publicado: (2022)

‘Is Insulin Right for Me?’ Development of a theory-informed, web-based resource for reducing psychological barriers to insulin therapy in type 2 diabetes
por: Holloway, Edith E, et al.
Publicado: (2021)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis
por: Bai, Xiaosu, et al.
Publicado: (2018)

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
por: Yavuz, Dilek Gogas, et al.
Publicado: (2015)

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2019)

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden
por: Bilir, S Pinar, et al.
Publicado: (2018)

Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden
por: Bilir, S Pinar, et al.
Publicado: (2018)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

A Pediatric Case of Ketosis-Prone Type 2 Diabetes Requiring Insulin Therapy
por: Matsuura, Misa, et al.
Publicado: (2022)

Web-based intervention to reduce psychological barriers to insulin therapy among adults with non-insulin-treated type 2 diabetes: study protocol for a two-armed randomised controlled trial of ‘Is insulin right for me?’
por: Holmes-Truscott, Elizabeth, et al.
Publicado: (2022)

A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study
por: Ito, Hiroyuki, et al.
Publicado: (2018)

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
por: Freemantle, Nick, et al.
Publicado: (2016)

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Early Insulin Treatment in Type 2 Diabetes: What are the pros?
por: Meneghini, Luigi F.
Publicado: (2009)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
por: Lebovitz, Harold E.
Publicado: (2011)

Use of insulin degludec/aspart after resolution of euglycemic diabetic ketoacidosis associated with dapagliflozin in a female patient with newly diagnosed maturity onset diabetes of the young type 3
por: Ayhan, Ihsan, et al.
Publicado: (2023)

Evaluating the User Preference and Level of Insulin Self-Administration Adherence in Young Patients With Type 1 Diabetes: Experience With Two Insulin Pen Needle Lengths
por: Al Hayek, Ayman A, et al.
Publicado: (2020)

Prolonged remission in latent autoimmune diabetes of adults (LADA): Is insulin resistance a major influence?
por: Rocha, José Vicente, et al.
Publicado: (2023)

Insulin Pump in Difficult to Control Type 2 Diabetes: A Single Center, Five Years' Experience
por: Singh, Priyamvada, et al.
Publicado: (2018)

The Role of Insulin and Insulin-like Growth Factors in the Increased Risk of Cancer in Diabetes
por: LeRoith, Derek, et al.
Publicado: (2011)

Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus
por: Alidrisi, Haider A, et al.
Publicado: (2021)

Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology
por: Sinha, Susmita, et al.
Publicado: (2022)

Insulin Therapy and Cancer
por: Home, Philip
Publicado: (2013)

Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Edina, Brenda C, et al.
Publicado: (2022)

Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin – a UK Perspective
por: Hellmund, Richard, et al.
Publicado: (2018)

Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
por: Liao, Hung-Wei, et al.
Publicado: (2017)

Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
por: Gough, Stephen CL, et al.
Publicado: (2016)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6jl66s5nsl5ah7f2ua968nkpnv